-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Gyre Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Gyre Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $4.54M, a 20.4% increase year-over-year.
- Gyre Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$79M, a 219% decline year-over-year.
- Gyre Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$85.5M, a 2081% decline from 2022.
- Gyre Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $4.31M.
- Gyre Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$87.9M, a 56.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)